Laverock Therapeutics secures Innovate UK award to advance i

Laverock Therapeutics secures Innovate UK award to advance immune effector cell therapeutics program

Laverock Therapeutics secures £1m funding via the Innovate UK Investor Partnerships Future Economy programme, supported by UKI2S. London, UK, 30th October 2023 / Sciad Newswire / Laverock Therapeutics, developer of a unique gene silencing platform for the creation of programmable advanced therapies, is pleased to an...

Related Keywords

United Kingdom , London , City Of , Oliver Sexton , Juliette Craggs , Tim Allsopp , Linkedin , United Kingdom Research , Sciad Communications , Investor Partnerships Programme , Science Seed Fund , Innovate United Kingdom , Investor Partnerships Future Economy , Sciad Newswire , Laverock Therapeutics , United Kingdom Innovation , Investor Partnerships , Chief Technology Officer , Investment Director ,

© 2025 Vimarsana